- American Society of Hematology - Hematology. org
As the world’s largest professional society serving clinicians and scientists around the world who are working to conquer blood diseases, ASH is fighting for hematology in the face of executive orders and other federal actions that threaten hematology research and, ultimately, the care of patients
- Research highlights from ASH 2025 conference | STATus Report
Tune into the latest episode of STATus Report for host Alex Hogan's recap of the influential #ASH25 medical conference
- Key Data, Interviews at the 2025 ASH Annual Meeting and Exposition
Key Takeaways The ASH Annual Meeting will showcase new therapies, emerging data, and scientific insights in hematology, with a focus on multiple myeloma, leukemia, and sickle cell disease Pharmacy Times will report on late-breaking abstracts, clinical trial findings, and new research, including interviews with leading hematologist-oncologists Key topics include minimal residual disease
- Leading Multiple Myeloma Results Unveiled at ASH 2025: Paradigm . . .
The 67th American Society of Hematology (ASH) Annual Meeting, held December 6-9, 2025, in Orlando, Florida, showcased groundbreaking clinical advances in multiple myeloma treatment from leading
- 15 Posts Not to Miss from ASH 2025, Part 1 - OncoDaily
The 67th American Society of Hematology (ASH) Annual Meeting Exposition will take place from December 6–9, 2025, in Orlando, Florida, offering both in-person and virtual participation
- American Society of Hematology
Regular features include in-depth cover stories on health care issues affecting the field, clinical consults, interviews with practicing hematologists, and updates on Society initiatives ASH News Daily, the official newspaper of the ASH annual meeting, highlights each day’s sessions and events
- ASH 2025 marked by ‘enduring activism’ and ‘cautious optimism’
ASH now runs the Center for Sickle Cell Disease Initiatives, which launched in 2015, and the disease was the topic of several special interest sessions at this year’s meeting
- Highlights From ASH 2025: Progress and Hope in AL Amyloidosis
Highlights From ASH 2025: Progress and Hope in AL Amyloidosis A report from Kristen Hsu, ARC’s Executive Director of Research Kristen Hsu at the ASH 2025 Annual Meeting The American Society of Hematology (ASH) Annual Meeting took place December 6–9 in Orlando, Florida, bringing together more than 30,000 clinicians, researchers, patient groups, and companies focused on blood diseases For
|